Cabibbo G, Celsa C, Alimenti E, Iavarone M, et al. Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced hepatocellular carcinoma: the dark side of the moon. Hepatology 2023 Jan 3. doi: 10.1097/HEP.0000000000000205.
PMID: 36626617